General Information
Allergan Neuropathy 004
A Multi-center, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose, Parallel Design, Dose Ranging Study of the Safety and Efficacy of XXX in Patients with Painful Diabetic Peripheral Neuropathy
| Protocol | 203818-004 |
|---|---|
| Identifier | 203818-004 |
| UID | b7679bf8-4ed3-4c68-a402-ae168a52a751 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetic Neuropathy |
| Launch Year | 2007 |
| NCT Number | - |
| Created | 2012-05-03 18:21 |
| Last Updated | 2012-05-03 18:21 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Allergan |
|---|---|
| Division | Allergan |
| Team | Allergan |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
